Novavax Aktie
WKN DE: A2PKMZ / ISIN: US6700024010
|
27.02.2025 14:07:10
|
Novavax Inc. Q4 Loss Drops In Line With Estimates
(RTTNews) - Novavax Inc. (NVAX) announced Loss for fourth quarter that decreased from last year in line with the Street estimates.
The company's bottom line totaled -$81.03 million, or -$0.51 per share. This compares with -$178.39 million, or -$1.44 per share, last year.
Analysts on average had expected the company to earn -$0.51 per share. Analysts' estimates typically exclude special items.
The company's revenue for the period fell 69.7% to $88.31 million from $291.34 million last year.
Novavax Inc. earnings at a glance (GAAP) :
-Earnings: -$81.03 Mln. vs. -$178.39 Mln. last year. -EPS: -$0.51 vs. -$1.44 last year. -Revenue: $88.31 Mln vs. $291.34 Mln last year.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Novavax Inc.mehr Nachrichten
|
05.08.25 |
Ausblick: Novavax zieht Bilanz zum jüngsten Jahresviertel (finanzen.net) |
Analysen zu Novavax Inc.mehr Analysen
Aktien in diesem Artikel
| Novavax Inc. | 7,31 | -0,10% |
|